Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
British Journal of Clinical Pharmacology|April 12, 2019
Investigation of the absolute bioavailability and human mass balance of navoximod, a novel IDO1 inhibitorShuguang Ma, Julia Suchomel, Evelyn Yanez, et al.European Journal of Drug Metabolism and Pharmacokinetics|April 4, 2014
Dose-dependent exposure and metabolism of GNE-892, a β-secretase inhibitor, in monkeys: contributions by P450, AO, and P-gpRyan Takahashi, Shuguang Ma, Qin Yue, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 9, 2016
Absorption, metabolism and excretion of cobimetinib, an oral MEK inhibitor, in rats and dogsRyan H Takahashi, Shuguang Ma, Qin Yue, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 4, 2024
Mass Balance, Metabolic Pathways, Absolute Bioavailability, and Pharmacokinetics of Giredestrant in Healthy SubjectsSmita Kshirsagar, Ya-Chi Chen, Jiajie Yu, et al.Journal of Cellular and Molecular Medicine|August 7, 2009
Side population of a murine mantle cell lymphoma model contains tumour-initiating cells responsible for lymphoma maintenance and disseminationFrancisco Vega, Yogesh Davuluri, Jeong Hee Cho-Vega, et al.Drug Metabolism Reviews|July 17, 2026
Bioactivation and reactivity research advances - 2025 year in reviewJoyce Liu, Upendra A Argikar, Pietro Brunetti, et al.The Journal of Molecular Diagnostics : JMD|July 21, 2026
The Critical Role of Preanalytical Factors in Validating Cytology Specimens for Hybrid-Capture Next-Generation Sequencing: From Smear to SequenceHolly Atwell, Sinchita Roy-Chowdhuri, Rana Seyedjafari, et al.Molecular & Cellular Proteomics : MCP|April 27, 2023
Meeting Report on the 2nd Chinese American Society for Mass Spectrometry Conference: Advancing Biological and Pharmaceutical Mass SpectrometryYue Chen, Ying Ge, Xianlin Han, et al.Bioorganic & Medicinal Chemistry Letters|December 4, 2014
Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenaseSharada Labadie, Peter S Dragovich, Jinhua Chen, et al.Bioorganic & Medicinal Chemistry Letters|January 22, 2022
Structure-based optimization of hydroxylactam as potent, cell-active inhibitors of lactate dehydrogenaseBinQing Wei, Kirk Robarge, Sharada S Labadie, et al.Pageof 6